Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease (vol 89, pg 807, 2021)

被引：0
|
作者：
Johnson, Eileanoir B.
Ziegler, Gabriel
Penny, William
Rees, Geraint
Tabrizi, Sarah J.
Scahill, Rachael I.
Gregory, Sarah
机构：
来源：
BIOLOGICAL PSYCHIATRY | 2021年 / 90卷 / 04期
关键词：
D O I：
10.1016/j.biopsych.2021.05.020
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：275 / 275
页数：1
相关论文
共 50 条
  • [21] Identifying modifiers of Huntington's disease progression (vol 16, pg 679, 2017)
    Saft, C.
    LANCET NEUROLOGY, 2017, 16 (09): : 683 - 683
  • [22] Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease (vol 101, pg 801, 2019)
    Tabrizi, Sarah J.
    Ghosh, Rhia
    Leavitt, Blair R.
    NEURON, 2019, 102 (04) : 899 - 899
  • [23] Gaitvariability as digital biomarker of disease severity in Huntington's disease (vol 47, pg 891, 2020)
    Gassner, Heiko
    Jensen, Dennis
    Marxreiter, Franz
    Kletsch, Anja
    Bohlen, Stefan
    Schubert, Robin
    Muratori, Lisa M.
    Eskofier, Bjoern
    Klucken, Jochen
    Winkler, Juergen
    Reilmann, Ralf
    Kohl, Zacharias
    JOURNAL OF NEUROLOGY, 2020, 267 (06) : 1602 - 1602
  • [24] Aducanumab (Aduhelm) for Alzheimer's Disease (vol 63, pg 105, 2021)
    Dunn, Billy
    Stein, Peter
    Cavazzoni, Patrizia
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1629): : 120 - 120
  • [25] No going home for hospitalized Huntington's disease patients (vol 20, pg 1316, 2005)
    Dubinsky, R. M.
    MOVEMENT DISORDERS, 2007, 22 (04) : 450 - 450
  • [26] Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease (vol 25, pg 9932, 2005)
    Valenza, Marta
    Rigamonti, Dorotea
    Goffredo, Donato
    Zuccato, Chiara
    Fenu, Simone
    Jamot, Laure
    Strand, Andrew
    Tarditi, Alessia
    Woodman, Ben
    Racchi, Marco
    Mariotti, Caterina
    Di Donato, Stefano
    Corsini, Alberto
    Bates, Gillian
    Pruss, Rebecca
    Olson, James M.
    Sipione, Simonetta
    Tartari, Marzia
    Cattaneo, Elena
    JOURNAL OF NEUROSCIENCE, 2020, 40 (38): : 7375 - 7375
  • [27] Faulty splicing and cytoskeleton abnormalities in Huntington's disease (vol 26, pg 772, 2016)
    Hernandez, Ivo H.
    BRAIN PATHOLOGY, 2017, 27 (03) : 408 - 408
  • [28] Therapies targeting DNA and RNA in Huntington's disease (vol 16, pg 837, 2017)
    Wild, E. J.
    Tabrizi, S. J.
    LANCET NEUROLOGY, 2017, 16 (12): : 954 - 954
  • [29] Targeting Huntingtin Expression in Patients with Huntington's Disease (vol 380, pg 2307, 2019)
    Tabrizi, S. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (14): : 1398 - 1398
  • [30] 22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium (vol 24, pg 1396, 2016 )
    Baig, Sheharyar S.
    Strong, Mark
    Rosser, Elisabeth
    Taverner, Nicola V.
    Glew, Ruth
    Miedzybrodzka, Zosia
    Clarke, Angus
    Craufurd, David
    Quarrell, Oliver W.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2017, 25 (11) : 1290 - 1290
12345